Efficacy of single-agent bortezomib vs. single-agent thalidomide in patients with relapsed or refractory multiple myeloma: a systematic comparison

OBJECTIVE: To conduct a systematic review of the efficacy of single-agent bortezomib vs. single-agent thalidomide in patients with relapsed/refractory multiple. METHODS: Publications in English from 1966 to June 2005 (MEDLINE, EMBASE, Cochrane library), publication reference lists, Janssen-Cilag dat...

Descripción completa

Detalles Bibliográficos
Autores principales: Prince, H Miles, Adena, Michael, Smith, Dell Kingsford, Hertel, Judy
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2007
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1974816/
https://www.ncbi.nlm.nih.gov/pubmed/17608711
http://dx.doi.org/10.1111/j.1600-0609.2007.00886.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1974816/
https://www.ncbi.nlm.nih.gov/pubmed/17608711
http://dx.doi.org/10.1111/j.1600-0609.2007.00886.x

Ejemplares similares